The intensification of beam conditioning doesn't influence both event-free survival (EFS) and overall survival (OS) of patients transplanted for non-Hodgkin's malignant lymphomas.

被引：0
|
作者：
Trneny, M [1 ]
Benesová, K [1 ]
Slaby, J [1 ]
Apltauerová, M [1 ]
Procházka, B [1 ]
Kobylka, P [1 ]
Klener, P [1 ]
机构：
[1] Gen Univ Hosp, Dept Med 1, Prague, Czech Republic
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
617
引用
收藏
页码：S178 / S178
页数：1
相关论文
共 38 条
  • [1] Aberrant T-Cell Antigen Expression in Classical Hodgkin Lymphoma Is Associated with Decreased Event-Free Survival (EFS) and Overall Survival (OS)
    Venkataraman, G.
    Traverse-Glehen, A.
    Song, J. Y.
    Eberle, F. C.
    Hanson, J. C.
    Dirnhofer, S.
    Tzankov, A.
    Heinze, G.
    Raffeld, M. A.
    Pittaluga, S.
    Jaffe, E. S.
    LABORATORY INVESTIGATION, 2011, 91 : 326A - 327A
  • [2] Aberrant T-Cell Antigen Expression in Classical Hodgkin Lymphoma Is Associated with Decreased Event-Free Survival (EFS) and Overall Survival (OS)
    Venkataraman, G.
    Traverse-Glehen, A.
    Song, J. Y.
    Eberle, F. C.
    Hanson, J. C.
    Dirnhofer, S.
    Tzankov, A.
    Heinze, G.
    Raffeld, M. A.
    Pittaluga, S.
    Jaffe, E. S.
    MODERN PATHOLOGY, 2011, 24 : 326A - 327A
  • [3] EVALUATION OF OVERALL SURVIVAL (OS) AND EVENT-FREE SURVIVAL (EFS) OF PAEDIATRIC SARCOMA PATIENTS - WEST OF SCOTLAND EXPERIENCE
    Ronghe, M.
    Murphy, D.
    Sastry, J.
    Donnelly, P.
    Macdonald, A.
    Cowie, F.
    Jones, R.
    Duncan, R.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S275 - S275
  • [4] Reduced-intensity conditioning regimen with BEAM/rituximab for patients with refractory non-Hodgkin's lymphomas.
    Khouri, IF
    Saliba, RM
    Okoroji, GJ
    Acholonu, S
    Maadani, F
    Hosing, C
    Champlin, RE
    BLOOD, 2004, 104 (11) : 637A - 637A
  • [5] Evaluation of event-free survival (EFS) as a surrogate for overall survival (OS) in patients with locally advanced esophageal carcinoma (LA EC) receiving definitive chemoradiotherapy (dCRT).
    Shah, Manish A.
    Xue, Weiguang
    Ramakrishnan, Karthik
    Zhou, Jenny
    Meng, Yan
    Bordia, Sonal
    Valderrama, Adriana
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 412 - 412
  • [6] Pretreatment Neutrophil to Lymphocyte Ratio Predicts Event Free and Overall Survival in Patients of Childhood T Cell Non-Hodgkin Lymphoma
    Patel, A.
    Biswas, B.
    Bakhshi, S.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S183 - S183
  • [7] Prospects for long term survival with minimal late effects in young patients with high grade non-Hodgkin's lymphomas.
    Haddy, TB
    Adde, MA
    Magrath, IT
    BLOOD, 1996, 88 (10) : 882 - 882
  • [8] Long-term event-free survival (EFS) after intensive therapy with etoposide, melphalan and autotransplant in patients failing front-line therapy for Hodgkin's disease and non-Hodgkin's lymphoma.
    Prince, HM
    Crump, M
    Imrie, K
    Stewart, AK
    Keating, A
    BLOOD, 1995, 86 (10) : 825 - 825
  • [9] RATIONALE-315: Event-free survival (EFS) and overall survival (OS) of neoadjuvant tislelizumab (TIS) plus chemotherapy (CT) with adjuvant TIS in resectable non-small cell lung cancer (NSCLC)
    Yue, D.
    Wang, W.
    Liu, H.
    Chen, Q.
    Chen, C.
    Liu, L.
    Zhang, P.
    Zhao, G.
    Yang, F.
    Han, G.
    Cheng, Y.
    Yu, B.
    Yang, Y.
    Chen, H.
    Jiang, J.
    Yao, B.
    Wang, S.
    Wang, R.
    Zheng, W.
    Wang, C.
    ANNALS OF ONCOLOGY, 2024, 35 (03) : 332 - 333
  • [10] REDUCED TOXICITY CONDITIONING (RTC) AND ALLOGENEIC STEM CELL TRANSPLANTATION (ALLOSCT) IN PEDIATRIC PATIENTS WITH HIGH-RISK SICKLE CELL DISEASE (SCD): ONE HUNDRED PERCENT EVENT-FREE SURVIVAL (EFS)/OVERALL SURVIVAL (OS) FOLLOWING SIBLING ALLOSCT
    Radhakrishnan, Kavita
    Bhatia, Monica
    Geyer, Mark
    Morris, Erin
    Baxter-Lowe, Lee Ann
    Cairo, Mitchell
    PEDIATRIC BLOOD & CANCER, 2012, 58 (07) : 1072 - 1073
1234